Research Topics

Paul C Trippier


Affiliation: Texas Tech University Health Sciences Center
Country: USA


  1. Zang T, Verma K, Chen M, Jin Y, Trippier P, Penning T. Screening baccharin analogs as selective inhibitors against type 5 17β-hydroxysteroid dehydrogenase (AKR1C3). Chem Biol Interact. 2015;234:339-48 pubmed publisher
  2. Verma K, Gupta N, Zang T, Wangtrakluldee P, Srivastava S, Penning T, et al. AKR1C3 Inhibitor KV-37 Exhibits Antineoplastic Effects and Potentiates Enzalutamide in Combination Therapy in Prostate Adenocarcinoma Cells. Mol Cancer Ther. 2018;17:1833-1845 pubmed publisher
    ..i>Mol Cancer Ther; 17(9); 1833-45. ©2018 AACR. ..
  3. Kinarivala N, Suh J, Botros M, Webb P, Trippier P. Pharmacophore elucidation of phosphoiodyn A - Potent and selective peroxisome proliferator-activated receptor ?/? agonists with neuroprotective activity. Bioorg Med Chem Lett. 2016;26:1889-93 pubmed publisher
  4. Trippier P. Selecting Good 'Drug-Like' Properties to Optimize Small Molecule Blood-Brain Barrier Penetration. Curr Med Chem. 2016;23:1392-407 pubmed